You’re Invited! Voices of Value Speak Up: Non-Small Cell Lung Cancer
Voices of value are speaking up!
On October 19th, Patients Rising and Aimed Alliance will launch Voices of Value Speak Up in St. Louis.
This special gathering will amplify the patient voice so it can be heard in the most important conversations addressing the emerging system of value frameworks.
Join our interactive conversation as patients are joined by advocates, doctors, economists and legal experts to define what value means to them. We believe these voices of value can make all the difference. Register for the event here.
- Wednesday, October 19th, 2016
- 6:00-8:30 PM VUE 17
- 1034 S. Brentwood Blvd.; 17th Floor
- St. Louis, MO 63117
Buffet dinner will be served. This program is free to the public and will be webcast live via Patients Rising YouTube channel and available online immediately following the event. Please visit the event page and our website for regular updates of special guests and contributors.
Voices of Value Speak Up is made possible with support from: Amgen | Bristol-Myers Squibb | Celgene | WOMEN
Voices of Value: Where is the Patient in the National Health Care Discussion?
Where is the patient in the national conversation about value and our healthcare?
We believe patients need to not only join the conversation and understand the conversation, but help lead the conversation. It is only by determining the concerns and goals of the patient, that the true measure of value in our health care system can be found.
Come hear the problem, hear the patients, hear the experts — and in the end hear some alternatives to the current path. This special gathering will amplify the patient voice so it can be heard in the most important conversations addressing the emerging system of value frameworks.
Voices of Value: What is Non-Small Cell Lung Cancer?
On October 19th, our Voices of Value event will focus on ensuring that patients with non-small cell lung cancer gain access to the right treatment.
What is non-small cell lung cancer?
According to the National Cancer Institute: “Non-small cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.” Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma are all subtypes of non-small cell lung cancer. The American Cancer Society says that non-small cell lung cancer is the most common type of lung cancer, encompassing about 85% of lung cancers.
There’s no cure for non-small cell lung cancer, and that means innovation — the potential development of new treatments — is the only long-term option for patients. Thankfully, health care experts describe “a sea change” in treatment options.
Learn more by checking out our “Beginner’s Guide to Non-Small Cell Lung Cancer.”
Voices of Value: Learn More about our Effort to Empower Patients
If there is one thing that we all agree upon, it is that every person is unique. This fact is especially important when it comes to patients fighting life-threatening diseases. For example, there are more than 200 different types of cancer, but no two individuals diagnosed with cancer will experience their disease in the same way and patients with the same type of cancer may respond very differently to the exact same cancer treatment therapy.
This reality is of central importance in defining the “value” of medicines from the standpoint of patients living with cancer and other serious diseases. And this is the reason for the Voices of Value, an initiative of Patients Rising to relay the indelible voice of patients on what “value” means to them. There is power in knowledge, there is strength in numbers and no patient is worth less than anyone else. It is time for patients’ voices to be heard.
If you have a story we should be sharing, join our community and let us know!